Chondrosarcoma is a rare tumor. In this study, we present a case with laryngeal chondrosarcoma that was treated by an endolaryngeal approach using an operation microscope. The patient remains disease-free to date, with no evidence of new or recurrent disease more than 3 years after the endolaryngeal surgery. The computerized tomography and endoscopic examinations did not reveal any recurrent disease, indicating the success of the endolaryngeal approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00405-003-0637-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case report: A laser and radiofrequency ablation in a laryngeal chondrosarcoma.
Int J Surg Case Rep
December 2024
Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne, 54519 Vandœuvre-lès-Nancy, France; CRAN, CNRS, UMR 7039, Université de Lorraine, Vandœuvre-lès-Nancy, France.
Introduction And Importance: Chondrosarcoma is a tumor which arises from cartilage, and whose apparition can occur in any site. However, it remains rare in the larynx. Management depends on the grade and the stage of the tumor at the time of the presentation.
View Article and Find Full Text PDFLaryngeal chondrosarcoma, a 30-year series.
Acta Otorrinolaringol Esp (Engl Ed)
September 2024
Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal.
Introduction And Objectives: Laryngeal chondrosarcoma is a rare laryngeal pathology arising from cartilaginous structures and is predominantly found in the cricoid cartilage. This study investigates its presentation, treatment modalities and patient outcomes.
Patients Or Materials And Methods: Retrospective study of laryngeal chondrosarcoma cases followed from 1992 to 2022 in the Otorhinolaryngology department of a cancer center - Instituto Português de Oncologia de Lisboa.
Laryngeal rare benign non-epithelial tumors and sarcomas emphasizing on chondrosarcomas: A literature review and a case presentation.
Pathol Res Pract
September 2024
Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa 41500, Greece.
Laryngeal rare tumors include benign and malignant tumors of epithelial, non-epithelial, or mesenchymal origin. Chondrosarcomas are the most common mesenchymal malignant tumors of the larynx. We performed a literature review (Pubmed/Medline; PRISMA 2020) to detect the frequency of published studies from 2021 to April 2024 regarding benign and malignant epithelial, non-epithelial, or mesenchymal rare tumors of the larynx, emphasizing laryngeal chondrosarcoma (LC) cases.
View Article and Find Full Text PDFTotal Laryngeal Transplant in the Setting of Active Laryngeal Malignancy.
Mayo Clin Proc
September 2024
Larynx and Trachea Transplantation Program, Mayo Clinic Arizona, Phoenix; Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic Arizona, Phoenix.
Laryngeal transplant (LT) is a promising option to restore quality of life in patients with severe laryngeal dysfunction or a laryngectomy. These patients may be tracheostomy tube dependent or gastrostomy tube dependent and may lose their ability to verbally communicate. The loss of these important functions frequently results in social isolation and a severe decrease in quality of life.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!